Cite
HARVARD Citation
Beca, J. et al. (2022). Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces. Clinical oncology. 34 (1), pp. e7-e17. [Online].